These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 29203236)

  • 1. Amylin - Its role in the homeostatic and hedonic control of eating and recent developments of amylin analogs to treat obesity.
    Boyle CN; Lutz TA; Le Foll C
    Mol Metab; 2018 Feb; 8():203-210. PubMed ID: 29203236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of amylin on eating and adiposity.
    Lutz TA
    Handb Exp Pharmacol; 2012; (209):231-50. PubMed ID: 22249817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amylin: Pharmacology, Physiology, and Clinical Potential.
    Hay DL; Chen S; Lutz TA; Parkes DG; Roth JD
    Pharmacol Rev; 2015 Jul; 67(3):564-600. PubMed ID: 26071095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amylin Acts in the Lateral Dorsal Tegmental Nucleus to Regulate Energy Balance Through Gamma-Aminobutyric Acid Signaling.
    Reiner DJ; Mietlicki-Baase EG; Olivos DR; McGrath LE; Zimmer DJ; Koch-Laskowski K; Krawczyk J; Turner CA; Noble EE; Hahn JD; Schmidt HD; Kanoski SE; Hayes MR
    Biol Psychiatry; 2017 Dec; 82(11):828-838. PubMed ID: 28237459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amylinergic control of food intake in lean and obese rodents.
    Boyle CN; Lutz TA
    Physiol Behav; 2011 Nov; 105(1):129-37. PubMed ID: 21324327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of amylinergic and melanocortinergic systems in the control of food intake and body weight in rodents.
    Roth JD; D'Souza L; Griffin PS; Athanacio J; Trevaskis JL; Nazarbaghi R; Jodka C; Athanacio J; Hoyt J; Forood B; Parkes DG
    Diabetes Obes Metab; 2012 Jul; 14(7):608-15. PubMed ID: 22276636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of pramlintide, rat and human amylin but not Aβ1-42 at human amylin receptors.
    Gingell JJ; Burns ER; Hay DL
    Endocrinology; 2014 Jan; 155(1):21-6. PubMed ID: 24169554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of energy homeostasis by amylin.
    Lutz TA
    Cell Mol Life Sci; 2012 Jun; 69(12):1947-65. PubMed ID: 22193913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amylin activates distributed CNS nuclei to control energy balance.
    Mietlicki-Baase EG; Hayes MR
    Physiol Behav; 2014 Sep; 136():39-46. PubMed ID: 24480072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination therapy with amylin and peptide YY[3-36] in obese rodents: anorexigenic synergy and weight loss additivity.
    Roth JD; Coffey T; Jodka CM; Maier H; Athanacio JR; Mack CM; Weyer C; Parkes DG
    Endocrinology; 2007 Dec; 148(12):6054-61. PubMed ID: 17761760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mediators of Amylin Action in Metabolic Control.
    Boyle CN; Zheng Y; Lutz TA
    J Clin Med; 2022 Apr; 11(8):. PubMed ID: 35456307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amylin, Another Important Neuroendocrine Hormone for the Treatment of Diabesity.
    Eržen S; Tonin G; Jurišić Eržen D; Klen J
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic amylin as a centrally acting satiating hormone.
    Lutz TA
    Curr Drug Targets; 2005 Mar; 6(2):181-9. PubMed ID: 15777188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GLP-1 and Amylin in the Treatment of Obesity.
    Jorsal T; Rungby J; Knop FK; Vilsbøll T
    Curr Diab Rep; 2016 Jan; 16(1):1. PubMed ID: 26699764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Creating the amylin story.
    Lutz TA
    Appetite; 2022 May; 172():105965. PubMed ID: 35183619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of amylin in satiation, adiposity and brain development.
    Lutz TA
    Forum Nutr; 2010; 63():64-74. PubMed ID: 19955774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pramlintide treatment reduces 24-h caloric intake and meal sizes and improves control of eating in obese subjects: a 6-wk translational research study.
    Smith SR; Blundell JE; Burns C; Ellero C; Schroeder BE; Kesty NC; Chen KS; Halseth AE; Lush CW; Weyer C
    Am J Physiol Endocrinol Metab; 2007 Aug; 293(2):E620-7. PubMed ID: 17505051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amylin improves the effect of leptin on insulin sensitivity in leptin-resistant diet-induced obese mice.
    Kusakabe T; Ebihara K; Sakai T; Miyamoto L; Aotani D; Yamamoto Y; Yamamoto-Kataoka S; Aizawa-Abe M; Fujikura J; Hosoda K; Nakao K
    Am J Physiol Endocrinol Metab; 2012 Apr; 302(8):E924-31. PubMed ID: 22275759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noradrenaline signaling in the LPBN mediates amylin's and salmon calcitonin's hypophagic effect in male rats.
    Boccia L; Le Foll C; Lutz TA
    FASEB J; 2020 Nov; 34(11):15448-15461. PubMed ID: 32985027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steve Woods's contribution to research on amylin's eating inhibitory effect.
    Lutz TA
    Physiol Behav; 2011 Apr; 103(1):25-30. PubMed ID: 21035478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.